Evidence map›Paper›PMID 40520474›Full record

ArticleOphthalmology science

A Hybrid Deep Learning-Based Approach for Visual Field Test Forecasting.

Ashkan Abbasi, Sowjanya Gowrisankaran, Wei-Chun Lin, Xubo Song, Bhavna Josephine Antony, Gadi Wollstein, Joel S Schuman, Hiroshi Ishikawa

Abstract read
In one paragraph

Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ashkan AbbasiDepartment of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon.
Sowjanya GowrisankaranDepartment of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon.
Wei-Chun LinDepartment of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon.
Xubo SongDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon.
Bhavna Josephine AntonyInformation Technology, Institute of Innovation, Science & Sustainability, Federation University, Ballarat, Australia.
Gadi WollsteinGlaucoma Service and Vickie and Jack Farber Vision Research Center, Wills Eye Hospital, Philadelphia, Pennsylvania.
Joel S SchumanGlaucoma Service and Vickie and Jack Farber Vision Research Center, Wills Eye Hospital, Philadelphia, Pennsylvania.
Hiroshi IshikawaDepartment of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon.

Funding

Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal ModelR01EY035174 · NEI · WILLS EYE HEALTH SYSTEM · PI Gadi Wollstein · 2023 to 2026
$2.9M
Biomarkers of Early Experimental Glaucoma - Resubmission - 1R01EY030770 · NEI · WILLS EYE HEALTH SYSTEM · PI WOLLSTEIN, GADI · 2020 to 2023
$2.2M
NEI NIH HHS R01 EY030770NEI NIH HHS R01 EY035174
6 · The paper itself

Abstract

Objective: Longitudinal assessment of visual field (VF) testing is essential in glaucoma management. Conventional VF forecasting methods require numerous prior tests, while deep learning techniques have shown promising results with fewer tests. This study introduces a hybrid deep learning framework to enhance flexibility and accuracy in VF test forecasting. Design: A retrospective longitudinal study using deep learning-based VF forecasting models. Subjects and Controls: A total of 1750 subjects (healthy and glaucoma patients) with 19 437 Humphrey VF (24-2 Swedish Interactive Threshold Algorithm) tests collected from longitudinal glaucoma cohorts at the University of Pittsburgh and New York University. Methods: Three deep learning models were trained for pointwise forecasting of VF test data: (1) a recurrent neural network (RNN), (2) CascadeNet-5, a convolutional neural network (CNN), and (3) Hybrid-VF-Net, our proposed method that combines an RNN with a CNN equipped with depthwise transformers for both spatial and temporal modeling. The results were analyzed from multiple perspectives, including the impact of varying the amount of prior input data and how data reliability and disease severity influence VF forecasting performance. Main Outcome Measures: Mean absolute error between predicted and actual VF test results was evaluated using five-fold cross-validation. Results: We found that specific VF locations benefited more from either local or temporal modeling, and our proposed methods outperformed the compared approaches using a hybrid strategy. Hybrid-VF-Net exhibited greater resilience to data reliability issues, particularly in managing high false-negative rates often seen in moderate-to-severe glaucoma cases due to increased test-retest variability. Additionally, it demonstrated improved performance with fewer prior VF tests, thus reducing the waiting time needed for progression analysis. Conclusions: The proposed Hybrid-VF-Net method outperformed the existing deep learning VF methods in terms of performance and robustness. Our findings highlight the influence of disease severity, data quality, and time displacement on forecasting performance, with certain VF locations benefiting more from either local or temporal modeling. Low reliability in data from moderate to advanced glaucoma cases continues to pose a challenge. Therefore, future research could refine temporal modeling and leverage larger datasets to further enhance predictive performance. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Deep learningGlaucoma progression predictionHybrid architecturePointwise visual field forecastingSpatial and temporal modeling

Identifiers

PMID40520474
PMCPMC12166726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.